Clinical Report: Utilizing Data from Wearable Devices to Enhance Patient Frailty Assessment
Background
Frailty is a critical factor affecting healthcare outcomes, particularly in older adults. Traditional assessments often miss subtle signs of functional decline, which wearable devices can capture through continuous monitoring. This integration could lead to earlier detection of frailty.
Data Highlights
No numerical data or trial data provided in the source material.
Key Findings
Wearable devices can capture real-time data on mobility, activity, and physiological signals, enhancing frailty assessments.
The Hospital Frailty Risk Score (HFRS) is a key tool that can integrate wearable data for better risk stratification.
Frailty-related risks are significant across all age groups, with higher in-hospital mortality rates observed particularly in the 65-74 age group.
Wearable technology has demonstrated feasibility in clinical decision-making, as shown by smartwatch-based atrial fibrillation screening.
Bias in wearable device performance can lead to disparities in healthcare outcomes, necessitating rigorous validation across diverse populations.
Regulatory clarity and reimbursement pathways are essential for the adoption of wearable technology in clinical practice.
Clinical Implications
Clinicians should consider integrating wearable technology into frailty assessments.
Conclusion
The integration of wearable devices into frailty assessments presents a promising opportunity to enhance patient care, but it requires careful consideration of biases and regulatory frameworks to ensure equitable implementation.
The judgment stemmed from controlled-substance prescriptions issued after William C. Gardner, DDS, no longer held the state licensure required for federal prescribing authority.
